公司资料
23andMe 股价、新闻与催化剂
- 股票代码:
- ME
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for ME.
公司概览
业务概览
23andMe is a consumer genetics and research company built around genetic testing, data services, and health-related insights. Its model is rooted in consumer engagement more than drug development.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, 23andMe sits in consumer genetics and health data.
商业模式特征
The business depends on consumer subscriptions, data monetization, and the ability to turn genetics into recurring value.
生物医药行业定位
23andMe is outside biotech proper and is better viewed as a consumer genetics and health-data platform.
未来催化剂
- 23andMe's catalysts are asset sales, balance-sheet actions, and any move that clarifies how consumer genetics and data fit into the next business model. The company is now more of a restructuring story than a growth story.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。